跳至主要内容
临床试验/JPRN-UMIN000023724
JPRN-UMIN000023724已完成未知

The prevention of progression in CKD of medication adherence to AST-120 in patients with non-dialysis chronic kidney disease (CKD) and significance of measurement indoxyl sulfate as an indicator of medication adherence - The prevention of progression in CKD of medication adherence to AST-120 in patients with non-dialysis chronic kidney disease (CKD) and significance of measurement indoxyl sulfate as an indicator of medication adherence

Jichi Medical University0 个研究点目标入组 100 人开始时间: 2016年8月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with a gastrointestinal disorder 2) AFR,RPGN(acute phase), Advanced nephrotic syndrome (albumin<2g/dl), Transplanted kidney 3) Severe heart failure (NYHA3 or more),Serious arrhythmia, Myocardial infarction or PCI within 6 months. 4) T1DM,and T2DM 5) AST, ALT less than 5 times as much as upper limit of standard value. 6) progressive cancer 7) Pregnant or women of childbearing potential unwilling to use effective means of contraception. 8) Patients who cannot signed an informed consent 9) Allergy to AST-120 10) Any other medical conditions disable to comply with the protocol

研究者

相似试验

The prevention of progression in CKD of medication... | 临床试验